The Lancet Infectious Diseases
@thelancetinfdis.bsky.social
The Lancet Infectious Diseases is the leading clinical infectious diseases journal for peer-reviewed research and review, comment, and news.
🌐 https://www.thelancet.com/journals/laninf/home
🌐 https://www.thelancet.com/journals/laninf/home
Pinned
Read our December issue!
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
New comment:
Strengthening global preparedness and response to arboviral disease threats: a call to action
www.thelancet.com/journals/lan...
Strengthening global preparedness and response to arboviral disease threats: a call to action
www.thelancet.com/journals/lan...
Strengthening global preparedness and response to arboviral disease threats: a call to action
Arthropod-borne viruses (arboviruses), particularly those transmitted by Aedes aegypti
and Aedes albopictus, are a growing global health threat. Approximately 70% of the
world's population is at risk ...
www.thelancet.com
November 25, 2025 at 8:36 AM
New comment:
Strengthening global preparedness and response to arboviral disease threats: a call to action
www.thelancet.com/journals/lan...
Strengthening global preparedness and response to arboviral disease threats: a call to action
www.thelancet.com/journals/lan...
New Research:
Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study
www.thelancet.com/journals/lan...
Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study
www.thelancet.com/journals/lan...
Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling...
No single algorithm was optimal across all settings. T-RDTs remain suitable for antenatal
screening, but the standard or modified T/NT-RDT might be preferable for populations
at high risk for syphilis...
www.thelancet.com
November 24, 2025 at 8:38 AM
New Research:
Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study
www.thelancet.com/journals/lan...
Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study
www.thelancet.com/journals/lan...
New comment:
The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action
www.thelancet.com/journals/lan...
The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action
www.thelancet.com/journals/lan...
The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action
The COVID-19 pandemic provided a stark, real-time demonstration of genomic surveillance's
power. By sequencing SARS-CoV-2, the global health community tracked viral evolution,
identified variants of c...
www.thelancet.com
November 24, 2025 at 8:37 AM
New comment:
The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action
www.thelancet.com/journals/lan...
The genomic surveillance gap: averting the antimicrobial resistance pandemic requires global equity and action
www.thelancet.com/journals/lan...
Read our December issue!
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
November 20, 2025 at 5:51 AM
Read our December issue!
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
Featuring testing obeldesivir for COVID-19 therapy, measles transmission patterns in Italy, and single dose of HPV vaccine in Costa Rica.
www.thelancet.com/issue/S1473-...
New Research
Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study
www.thelancet.com/journals/lan...
Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study
www.thelancet.com/journals/lan...
Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study
The 2023–2024 M pneumoniae epidemic in France resulted in a substantial paediatric
hospitalisation burden. Although severe cases were uncommon, children older than 11
years, those with asthma, other c...
www.thelancet.com
November 20, 2025 at 5:45 AM
New Research
Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study
www.thelancet.com/journals/lan...
Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study
www.thelancet.com/journals/lan...
New Research:
National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study
www.thelancet.com/journals/lan...
National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study
www.thelancet.com/journals/lan...
National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study
A spatially targeted vaccine campaign would be most effective in reducing JEV burden;
however, it would still not meet standard cost-effectiveness targets.
www.thelancet.com
November 19, 2025 at 4:07 PM
New Research:
National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study
www.thelancet.com/journals/lan...
National burden of and optimal vaccine policy for Japanese encephalitis virus in Bangladesh: a seroprevalence and modelling study
www.thelancet.com/journals/lan...
Reposted by The Lancet Infectious Diseases
The role of AI in infectious diseases is emerging—offering new opportunities for infection prevention, detection & control.
Explore developments & practical applications ⤵️
spkl.io/63323Ad83c @thelancetinfdis.bsky.social #WorldAMRAwarenessWeek
Explore developments & practical applications ⤵️
spkl.io/63323Ad83c @thelancetinfdis.bsky.social #WorldAMRAwarenessWeek
November 19, 2025 at 12:03 PM
The role of AI in infectious diseases is emerging—offering new opportunities for infection prevention, detection & control.
Explore developments & practical applications ⤵️
spkl.io/63323Ad83c @thelancetinfdis.bsky.social #WorldAMRAwarenessWeek
Explore developments & practical applications ⤵️
spkl.io/63323Ad83c @thelancetinfdis.bsky.social #WorldAMRAwarenessWeek
New Research
Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis
www.thelancet.com/journals/lan...
Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis
www.thelancet.com/journals/lan...
Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis
We identified substantial ongoing morbidity and mortality due to typhoid fever in
Africa and Asia, in facility-based sites, and across age groups. This updated evidence
can be used to support decision...
www.thelancet.com
November 13, 2025 at 10:43 AM
New Research
Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis
www.thelancet.com/journals/lan...
Complications and mortality of typhoid fever: an updated global systematic review and meta-analysis
www.thelancet.com/journals/lan...
New Research
Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study
www.thelancet.com/journals/lan...
Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study
www.thelancet.com/journals/lan...
Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study
Although performance of the NG-Test Monkeypox antigen RDT did not fully meet WHO Target
Product Profile benchmarks, driven mainly by lower sensitivity in DR Congo, results
in Uganda were more encourag...
www.thelancet.com
November 13, 2025 at 10:41 AM
New Research
Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study
www.thelancet.com/journals/lan...
Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study
www.thelancet.com/journals/lan...
New Research
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial
www.thelancet.com/journals/lan...
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial
www.thelancet.com/journals/lan...
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escala...
A single dose of ChAdOx1 RVF vaccine seemed to be safe, tolerable, and immunogenic
in healthy adults in an RVF-endemic setting, eliciting humoral and cellular immunity.
Further evaluation of the 5·0 ×...
www.thelancet.com
November 12, 2025 at 9:01 AM
New Research
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial
www.thelancet.com/journals/lan...
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial
www.thelancet.com/journals/lan...
Reposted by The Lancet Infectious Diseases
@seanong.bsky.social takes to the next level analysis of the BALANCE trial (7 vs 14 days of antibiotics) and impact of protocol non-adherence (there was about 20% non-adherence to protocol durations).
Read his thread and read his paper!
@thelancetinfdis.bsky.social @thedohertyinst.bsky.social
Read his thread and read his paper!
@thelancetinfdis.bsky.social @thedohertyinst.bsky.social
Hot off the press at @thelancetinfdis.bsky.social: our paper diving into non-adherence in the BALANCE trial. We identify factors associated with protocol non-adherence, and evaluate the impact of potential bias on trial results.
authors.elsevier.com/a/1m5He5E-Uo...
@steventong.bsky.social #IDSky
authors.elsevier.com/a/1m5He5E-Uo...
@steventong.bsky.social #IDSky
authors.elsevier.com
November 12, 2025 at 1:30 AM
@seanong.bsky.social takes to the next level analysis of the BALANCE trial (7 vs 14 days of antibiotics) and impact of protocol non-adherence (there was about 20% non-adherence to protocol durations).
Read his thread and read his paper!
@thelancetinfdis.bsky.social @thedohertyinst.bsky.social
Read his thread and read his paper!
@thelancetinfdis.bsky.social @thedohertyinst.bsky.social
New Research
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
www.thelancet.com/journals/lan...
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
www.thelancet.com/journals/lan...
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
Non-adherence in BALANCE was significantly associated with a range of important prognostic
factors, which might have introduced bias. Causal inference methods addressing this
bias showed a consistent ...
www.thelancet.com
November 12, 2025 at 8:58 AM
New Research
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
www.thelancet.com/journals/lan...
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
www.thelancet.com/journals/lan...
New Personal View
Post-tuberculosis lung disease: a case definition for use in research studies
www.thelancet.com/journals/lan...
Post-tuberculosis lung disease: a case definition for use in research studies
www.thelancet.com/journals/lan...
Post-tuberculosis lung disease: a case definition for use in research studies
Despite growing awareness of the substantial burden of long-term pulmonary impairment
among tuberculosis survivors, marked variability in how post-tuberculosis lung disease
is defined across research ...
www.thelancet.com
November 11, 2025 at 8:13 AM
New Personal View
Post-tuberculosis lung disease: a case definition for use in research studies
www.thelancet.com/journals/lan...
Post-tuberculosis lung disease: a case definition for use in research studies
www.thelancet.com/journals/lan...
New Review
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update
www.thelancet.com/journals/lan...
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update
www.thelancet.com/journals/lan...
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update
The fungal diagnostic landscape is evolving; whereas previously, traditional culture-based
methods dominated, most invasive fungal disease is now diagnosed with non-culture-based
tests, including dire...
www.thelancet.com
November 11, 2025 at 8:12 AM
New Review
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update
www.thelancet.com/journals/lan...
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update
www.thelancet.com/journals/lan...
Reposted by The Lancet Infectious Diseases
Our November issue is now online:
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza
#IDSky #ClinMicro #OA
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza
#IDSky #ClinMicro #OA
November 8, 2025 at 9:38 PM
Our November issue is now online:
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza
#IDSky #ClinMicro #OA
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza
#IDSky #ClinMicro #OA
New Comment
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease
www.thelancet.com/journals/lan...
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease
www.thelancet.com/journals/lan...
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease
Long COVID is an umbrella term for the heterogeneous long-term consequences of SARS-CoV-2
infection. It encompasses a wide spectrum of phenotypes (sometimes overlapping), and
its underlying mechanisms...
www.thelancet.com
November 9, 2025 at 7:52 PM
New Comment
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease
www.thelancet.com/journals/lan...
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease
www.thelancet.com/journals/lan...
New Research
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study
www.thelancet.com/journals/lan...
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study
www.thelancet.com/journals/lan...
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study
Individuals previously infected with MPXV show strong and durable immunological memory
lasting up to 2 years after infection, in contrast to the less robust and shorter-lived
response observed after M...
www.thelancet.com
November 9, 2025 at 7:48 PM
New Research
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study
www.thelancet.com/journals/lan...
Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study
www.thelancet.com/journals/lan...
New Research
Immunogenicity and safety of an 18-month booster dose
of the VLA15 Lyme borreliosis vaccine candidate after primary
immunisation in children, adolescents, and adults in the USA:
a randomised, observer-blind, placebo-controlled, phase 2 trial
www.thelancet.com/journals/lan...
Immunogenicity and safety of an 18-month booster dose
of the VLA15 Lyme borreliosis vaccine candidate after primary
immunisation in children, adolescents, and adults in the USA:
a randomised, observer-blind, placebo-controlled, phase 2 trial
www.thelancet.com/journals/lan...
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer...
The safety and robust anamnestic immune responses associated with VLA15 boosting support
its use as a strategy to increase anti-OspA antibody levels before tick season among
children, adolescents, and...
www.thelancet.com
November 9, 2025 at 7:46 PM
New Research
Immunogenicity and safety of an 18-month booster dose
of the VLA15 Lyme borreliosis vaccine candidate after primary
immunisation in children, adolescents, and adults in the USA:
a randomised, observer-blind, placebo-controlled, phase 2 trial
www.thelancet.com/journals/lan...
Immunogenicity and safety of an 18-month booster dose
of the VLA15 Lyme borreliosis vaccine candidate after primary
immunisation in children, adolescents, and adults in the USA:
a randomised, observer-blind, placebo-controlled, phase 2 trial
www.thelancet.com/journals/lan...
New Research
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
www.thelancet.com/journals/lan...
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
www.thelancet.com/journals/lan...
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The GBD 2023 Chagas disease estimates are notably higher than previous GBD estimates,
reflecting additional data and methodological improvements, and those published by
the Pan American Health Organiz...
www.thelancet.com
November 5, 2025 at 8:35 AM
New Research
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
www.thelancet.com/journals/lan...
Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
www.thelancet.com/journals/lan...
New Comment
G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults
www.thelancet.com/journals/lan...
G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults
www.thelancet.com/journals/lan...
G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults
Ending tuberculosis is more than just a global health necessity; it is fundamental
to sustainable development and global health security. With at least 10 million new
cases and more than 1 million dea...
www.thelancet.com
November 5, 2025 at 8:32 AM
New Comment
G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults
www.thelancet.com/journals/lan...
G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults
www.thelancet.com/journals/lan...
Reposted by The Lancet Infectious Diseases
The November issue is now live! www.thelancet.com/journals/lan...
Post-partum haemorrhage
www.thelancet.com/journals/lan...
Impact of breastfeeding on the global burden of NCDs in mothers and children www.thelancet.com/journals/lan...
Vaccine ecosystem in Africa www.thelancet.com/journals/lan...
Post-partum haemorrhage
www.thelancet.com/journals/lan...
Impact of breastfeeding on the global burden of NCDs in mothers and children www.thelancet.com/journals/lan...
Vaccine ecosystem in Africa www.thelancet.com/journals/lan...
November 3, 2025 at 1:03 PM
The November issue is now live! www.thelancet.com/journals/lan...
Post-partum haemorrhage
www.thelancet.com/journals/lan...
Impact of breastfeeding on the global burden of NCDs in mothers and children www.thelancet.com/journals/lan...
Vaccine ecosystem in Africa www.thelancet.com/journals/lan...
Post-partum haemorrhage
www.thelancet.com/journals/lan...
Impact of breastfeeding on the global burden of NCDs in mothers and children www.thelancet.com/journals/lan...
Vaccine ecosystem in Africa www.thelancet.com/journals/lan...
📅 Marco De Ambrogi will be attending ASTMH 2025, #TropMed25, November 9-13, 2025 in Toronto, Ontario, Canada on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
November 4, 2025 at 3:50 PM
📅 Marco De Ambrogi will be attending ASTMH 2025, #TropMed25, November 9-13, 2025 in Toronto, Ontario, Canada on behalf of The Lancet Infectious Diseases!
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0
Reposted by The Lancet Infectious Diseases
Derivation and external validation of community-acquired #pneumonia subphenotypes in Southeast Asia: a secondary analysis of prospective cohort studies
These subphenotypes may represent unique targets for future #CAP interventional trials
www.thelancet.com/journals/ecl...
#MedSky
These subphenotypes may represent unique targets for future #CAP interventional trials
www.thelancet.com/journals/ecl...
#MedSky
October 29, 2025 at 12:08 PM
Derivation and external validation of community-acquired #pneumonia subphenotypes in Southeast Asia: a secondary analysis of prospective cohort studies
These subphenotypes may represent unique targets for future #CAP interventional trials
www.thelancet.com/journals/ecl...
#MedSky
These subphenotypes may represent unique targets for future #CAP interventional trials
www.thelancet.com/journals/ecl...
#MedSky
New Research
Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial
www.thelancet.com/journals/lan...
Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial
www.thelancet.com/journals/lan...
Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiori...
Voriconazole was not superior to itraconazole for treating chronic pulmonary aspergillosis
and was associated with a significantly higher incidence of adverse events. Our findings
support the continue...
www.thelancet.com
October 30, 2025 at 9:53 AM
New Research
Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial
www.thelancet.com/journals/lan...
Oral itraconazole versus oral voriconazole for treatment-naive patients with chronic pulmonary aspergillosis in India (VICTOR-CPA trial): a single-centre, open-label, randomised, controlled, superiority trial
www.thelancet.com/journals/lan...